Lisa Zuckerwise

Dr. Lisa Zuckerwise

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
LZLisa Zuckerwise
Lisa Zuckerwise
ACAmanda M. Craig
Amanda M. Craig
JNJm. Newton
Jm. Newton
SZShillin Zhao
Shillin Zhao
KBKelly A. Bennett
Kelly A. Bennett
MCMarta A. Crispens
Marta A. Crispens

1 January 2015 in Urogynecology
Verified
Journal Article
Open access
ALAva Leegant
Ava Leegant
LZLisa Zuckerwise
Lisa Zuckerwise
KDKeith Downing
Keith Downing
JBJurriaan Brouwer-Visser
Jurriaan Brouwer-Visser
CZChangcheng Zhu
Changcheng Zhu
GHGloria S. Huang
Gloria S. Huang
Objectives This study was undertaken to evaluate the expression of transforming growth factor β1 (TGF-β1) and matrix metalloproteinase 9 (MMP-9), key regulators of the extracellular matrix composition, in the uterosacral ligaments (USLs) of women with pelvic organ prolapse (POP) compared with controls. Methods Under an institutional review board approval, USL samples were obtained from women undergoing vaginal hysterectomy for stage 2 or greater POP (cases, n = 21) and from women without POP undergoing vaginal hysterectomy for benign indications (controls, n = 19). Hematoxylin and eosin and trichrome staining were performed on the USL sections, and the distribution of smooth muscle and fibrous tissue were quantified. Immunohistochemical staining was performed using anti–TGF-β1 and anti–MMP-9 antibodies. The expressions of TGF-β1 and MMP-9 were evaluated by the pathologist, who was blinded to all clinical data. Results Transforming growth factor β1 expression positively correlated with MMP-9 expression (R = 0.4, P = 0.01). The expressions of TGF-β1 and MMP-9 were similar in subjects with POP versus controls. There was a significant increase in fibrous tissue (P = 0.008) and a corresponding decrease in smooth muscle (P = 0.03), associated with increasing age. The TGF-β1 expression, but not MMP-9 expression, also significantly increased with age (P = 0.02). Discussion Although our study uncovered age-related alterations in USL composition and TGF-β1 expression, there was no difference in the expression of TGF-β1 or MMP-9 in the subjects with POP versus controls.

1 August 2012 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
LZLisa Zuckerwise
Lisa Zuckerwise
EWErika F. Werner
Erika F. Werner
CPChristian M. Pettker
Christian M. Pettker
EMErin K. McMahon-Brown
Erin K. McMahon-Brown
STStephen F. Thung
Stephen F. Thung
CHChristina S. Han
Christina S. Han
Increased insulin requirements in pregnancy can hinder attainment of glycemic control in diabetic patients. U-500 insulin is a concentrated form of regular insulin that can be a valuable tool in the treatment of patients with severe insulin resistance. A 24-year-old woman with pregestational diabetes mellitus experienced increasing insulin requirements during pregnancy, peaking at 650 units daily. The frequent, large-volume injections of standard-concentration insulin were poorly tolerated by the patient and resulted in nonadherence. She subsequently achieved glycemic control on thrice-daily U-500 insulin. Pregnancy exacerbates insulin resistance in diabetic patients, and these patients may require high doses of insulin. U-500 insulin is an effective alternative for patients with severe insulin resistance and should be considered for pregnant women with difficulty achieving glycemic control.

1 February 2020 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Closed access
LZLisa Zuckerwise
Lisa Zuckerwise
LHLaura C. Ha
Laura C. Ha
SOSarah S. Osmundson
Sarah S. Osmundson
ETEmily W. Taylor
Emily W. Taylor
JNJ Newton
J Newton

1 July 2021 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Open access
LHLaura C. Ha
Laura C. Ha
ACAmanda Craig
Amanda Craig
MGMatthew R. Grace
Matthew R. Grace
SOSarah S. Osmundson
Sarah S. Osmundson
ETEmily W. Taylor
Emily W. Taylor
LZLisa Zuckerwise
Lisa Zuckerwise
Gastroschisis and omphalocele are congenital abdominal wall defects in which the bowel and other abdominal contents extrude from the fetal abdominal cavity. Standard formulas for estimated fetal weight using ultrasound include fetal abdominal circumference measurement and have a range of error of approximately 10%. It is unknown whether the accuracy of estimated fetal weight assessment is compromised in fetuses with abdominal wall defects because of the extrusion of abdominal contents. This study aimed to assess the accuracy of standard estimated fetal weight assessment in fetuses with abdominal wall defects by comparing prenatal assessment of fetal weight with actual birthweight. A retrospective cohort study of fetuses diagnosed with gastroschisis or omphalocele was performed at a single center from 2012 to 2018. Fetuses with additional anomalies or confirmed chromosome abnormalities were excluded. Estimated fetal weight was calculated using the Hadlock formula. Published estimates of fetal growth rate were used to establish a projected estimated fetal weight at birth from the final growth ultrasound, and the percent difference between projected estimated fetal weight at birth and actual birthweight was calculated. The Wilcoxon rank-sum test was used to examine the difference between projected estimated fetal weight and actual birthweight. We had complete data for 112 fetuses with abdominal wall defects, including 85 with gastroschisis and 27 with omphalocele. The median (interquartile range) projected estimated fetal weight was similar to median birthweight, at 2283 g (interquartile range, 2000-2810) and 2306 g (interquartile range, 1991-264), respectively, which did not represent a statistically significant difference between projected estimated fetal weight and actual birthweight (P=.32). The median percent error was 6.8 (3.1-12.8). In addition, we did not find any statistical difference between projected estimated fetal weight and actual birthweight in patients with gastroschisis (P=.52) or omphalocele (P=.35) individually. Estimated fetal weight was underestimated in most cases (n=68 [60.7%]). In fetuses with abdominal wall defects, standard measurement of fetal weight shows an accuracy that is at least comparable with previously established margins of error for ultrasound assessment of fetal weight. Standard estimated fetal weight assessment remains an appropriate method of estimating fetal weight in these fetuses.

Ann Kavanaugh-McHughAnn Kavanaugh-McHugh
Ann Kavanaugh-McHugh
LZLisa Zuckerwise
Lisa Zuckerwise
SKStacy Ann Stratemann Killen
Stacy Ann Stratemann Killen
EMEmily A. Morris
Emily A. Morris
RSRachel T. Sullivan
Rachel T. Sullivan
LFLindsay Freud
Lindsay Freud
Collaborative multicenter research has significantly increased our understanding of fetal Ebstein anomaly, delineating risk factors for adverse outcomes as well as predictors of postnatal management. These data are incorporated into prenatal care and therapeutic strategies and inform family counseling and delivery planning to optimize care. This report details the translation of findings from multicenter studies into multidisciplinary prenatal care for a fetus with Ebstein anomaly, supraventricular tachycardia, and a circular shunt, including transplacental therapy to control arrhythmias and achieve ductal constriction, informed and coordinated delivery room management, and planned univentricular surgical palliation.